Market Movers (8-K)
See all →NYSE
ADNT
Adient PLCAdient plc presented at the J.P. Morgan Auto Conference on August 13, 2026, discussing resilient FY26 execution and building momentum for FY27 with a focus on sustainable value creation.
NYSE
ADNT
Adient PLCAdient plc reported third quarter 2026 financial results showing increased net sales but a decrease in net income and diluted earnings per share compared to the prior year.
Worse than expected
NYSE
ADNT
Adient PLCAdient plc announced that its Executive Vice President and Chief Financial Officer, Mark Oswald, intends to resign from his position by December 31, 2026.
NYSE
ADNT
Adient PLCAdient plc provided an update on its China business, highlighting strong sales growth, new customer wins, and strategic investments in innovation and automation.
Better than expected
NYSE
ADNT
Adient PLCAdient plc reported second quarter 2026 financial results, with net sales increasing to $3.865 billion and a net income attributable to Adient of $27 million.
NYSE
ADNT
Adient PLCAdient plc reported a net loss attributable to shareholders of $22 million for the first quarter ended December 31, 2025, despite an increase in net sales and adjusted EBITDA.
Worse than expected
Quarterly Earnings (10-Q)
See all →NYSE
ADNT
Adient PLCAdient plc announced its second quarter fiscal year 2026 results, with net sales increasing by 7% to $3.865 billion, driven by favorable currency impacts and higher production volumes in the Americas and Asia.
NYSE
ADNT
Adient PLCAdient plc reported a net loss of $22 million in Q1 fiscal 2026, driven by increased tax expenses and production challenges, despite a 4.3% rise in net sales.
Worse than expected
NYSE
ADNT
Adient PLCAdient plc reported a return to net income in Q3 2025 driven by favorable pricing and operating performance, despite a significant goodwill impairment impacting year-to-date results.
Capital raise
NYSE
ADNT
Adient PLCAdient's Q2 2025 results reveal a significant net loss primarily due to a $333 million goodwill impairment charge in the EMEA region.
Worse than expected
NYSE
ADNT
Adient PLCAdient's Q1 2025 net sales decreased by 4.5% year-over-year, impacted by lower production volumes and unfavorable material economics.
Worse than expected
NYSE
ADNT
Adient PLCAdient plc's Q3 2024 results show a decrease in net sales and a net loss, impacted by lower production volumes and restructuring costs, despite some positive adjustments.
Worse than expected
Delay expected
Annual Reports (10-K)
NYSE
ADNT
Adient PLCAdient plc reported a net loss of $281 million for fiscal year 2025, primarily driven by a $333 million goodwill impairment in its EMEA segment, despite slight revenue decline and improved gross profit margin.
Worse than expected
NYSE
ADNT
Adient PLCAdient's 2024 annual report reveals a challenging year marked by decreased sales and profitability due to lower production volumes and macroeconomic pressures, while highlighting strategic investments in technology and sustainability.
Worse than expected
Insider Trading (Form 4)
See all →NYSE
ADNT
Adient PLCAdient plc EVP of EMEA David Herberg sold 699 ordinary shares at a weighted average price of $22.58.
NYSE
ADNT
Adient PLCAdient plc executive James Conklin was granted 22,872 restricted stock units as part of company compensation.
NYSE
ADNT
Adient PLCAdient plc Director Frederick A. Henderson acquired 12,429 ordinary shares as compensation, increasing his total beneficial ownership to 104,614 shares.
NYSE
ADNT
Adient PLCAdient plc Director Jodi Euerle Eddy received 8,208 ordinary shares as compensation for her service, increasing her direct beneficial ownership to 24,551 shares.
NYSE
ADNT
Adient PLCAdient plc Director Jose M. Gutierrez acquired 8,208 ordinary shares as compensation, increasing his beneficial ownership to 55,349 shares.
NYSE
ADNT
Adient PLCAdient plc Director Richard Goodman acquired 8,208 ordinary shares as compensation, increasing his total beneficial ownership to 58,985 shares.
Proxy Statements (Def-14A)
NYSE
ADNT
Adient PLCAdient PLC announces its 2026 Annual General Meeting to vote on director elections, auditor ratification, executive compensation, and share issuance authorities.
Capital raise
NYSE
ADNT
Adient PLCAdient plc announced its 2026 Annual General Meeting of Shareholders, outlining proposals for director elections, auditor ratification, executive compensation, and share issuance authority.
Capital raise
Worse than expected
NYSE
ADNT
Adient PLCAdient PLC is holding its Annual General Meeting on March 11, 2025, where shareholders will vote on the election of directors, ratification of the auditor, executive compensation, and other important proposals.
NYSE
ADNT
Adient PLCAdient PLC has scheduled its 2025 Annual General Meeting for March 11, 2025, to vote on director elections, auditor ratification, executive compensation, and other corporate matters.
Schedule 13G - Passive Investments
See all →NYSE
ADNT
Adient PLCThe Vanguard Group reports 0% beneficial ownership in Adient PLC following an internal realignment of its reporting structure.
NYSE
ADNT
Adient PLCSCHEDULE: FMR LLC Updates Adient PLC Stake to 2.0%
FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, disclosing a 2.0% beneficial ownership stake in Adient PLC as of December 31, 2025.
NYSE
ADNT
Adient PLCFMR LLC and Abigail P. Johnson have reported a 6.1% beneficial ownership stake in Adient PLC's common stock as of September 30, 2025.
NYSE
ADNT
Adient PLCDimensional Fund Advisors LP has reported a 5.2% beneficial ownership stake in Adient PLC, holding 4,215,764 common shares as of September 30, 2025.
NYSE
ADNT
Adient PLCHotchkis and Wiley Capital Management, LLC has disclosed a 3.87% beneficial ownership stake in Adient plc's Ordinary Shares.
NYSE
ADNT
Adient PLCThe Vanguard Group has reported a 5.12% beneficial ownership stake in Adient PLC, held for passive investment purposes.